MarketHub · Packaging · Global

Healthcare Contract Packaging Services Market Size and Share - Growth Analysis Report and Forecast Trends 2026-2030

Healthcare contract packaging services involve outsourced packaging solutions for pharmaceuticals, medical devices, and healthcare products, covering primary, secondary, and tertiary packaging as well as serialization and labeling. The global market is valued at approximately $30 billion in 2025 and is projected to grow at a compound annual growth rate of roughly 10.5 percent, with some projections reaching between $61 billion and $69 billion by the early 2030s. Key market forces include the rising volume of generic and biosimilar drug production, increasingly stringent regulatory requirements for track-and-trace capabilities, and growing demand for flexible manufacturing capacity among pharmaceutical companies seeking to reduce capital expenditures.

Market size · 2025
$30 billion
CAGR · 2025–2030
10.5%
Forecast · 2030
$49.4 billion
Basis
Claight Analysis
Market size (USD)
Base year 2025
Official data · Claight AnalysisForecast
Market size and forecast are Claight Analysis, informed by public research.
Forecast
2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
2025 base: $30bn2030 est: $49.4bn
Read the full Healthcare Contract Packaging Services Market Report report →

Market Overview

Healthcare contract packaging services encompass outsourced packaging operations for prescription drugs, over-the-counter medicines, medical devices, and diagnostic products. Contract packaging organizations, or CPOs, provide end-to-end solutions ranging from primary packaging such as blister packs and vials to secondary packaging including cartons and inserts, as well as serialization, labeling, and logistics support. The global market is valued at approximately $30 billion in 2025 and is on a strong upward trajectory, with projections reaching between $61 billion and $69 billion by the early 2030s depending on methodology and scope.

  • Market valued at approximately $30 billion in 2025, growing at roughly 10.5 percent CAGR
  • Broad market definitions can place overall healthcare packaging at over $160 billion, making contract services a significant subsegment
  • Services span primary, secondary, and tertiary packaging, serialization, kitting, and logistics fulfillment

Growth Drivers

The expanding pipeline of generic drugs and biosimilars is a primary catalyst, as these products require specialized packaging at scale but lack the in-house manufacturing capacity of many smaller pharmaceutical firms. Regulatory mandates for product traceability and anti-counterfeiting, such as the U.S. Drug Supply Chain Security Act and the European Union's Falsified Medicines Directive, are compelling manufacturers to invest in serialization infrastructure that many prefer to outsource to contract providers. Meanwhile, the rising prevalence of chronic diseases and an aging global population are driving higher volumes of medications and medical devices that require professional packaging services.

  • Increasing production of generic and biosimilar drugs drives demand for scalable contract packaging capacity
  • Stringent global track-and-trace and serialization regulations require specialized technical expertise and investment
  • Growth in biologics, personalized medicines, and specialty drugs calls for flexible, compliant packaging solutions
Want a deeper cut on Healthcare Contract Packaging Services Market Report? We build bespoke studies on request.
Connect to an analyst →

Segmentation and Regional Analysis

The market is segmented by packaging type, including primary packaging such as bottles, blister packs, vials, and ampoules, as well as secondary packaging such as cartons, labels, and inserts. Material-based segmentation includes plastics, paper and paperboard, aluminum, and specialty films, with plastics representing the largest share due to their barrier properties and versatility. North America commands the largest regional share, supported by a dense concentration of pharmaceutical and biotechnology companies, while Europe follows with strong regulatory frameworks driving serialization requirements, and Asia-Pacific is the fastest-growing region led by expanding drug manufacturing in India and China.

  • Primary packaging accounts for the largest segment, with blister packs and bottles dominating demand
  • North America leads in market share, with Europe second and Asia-Pacific showing the fastest growth rate
  • Material segments include plastics, paperboard, aluminum laminates, and specialized films for sterile and moisture-sensitive products

Trends and Outlook

What are the recent trends and outlook?

Smart packaging technologies incorporating QR codes, RFID tags, and near-field communication are gaining traction as manufacturers seek enhanced supply chain visibility and patient engagement capabilities. The rapid growth of personalized medicine and cell and gene therapies is creating demand for niche, small-batch packaging solutions with ultra-low minimum order quantities and strict temperature control requirements. Sustainability is increasingly shaping packaging material selection, with a shift toward recyclable and bio-based materials driven by both environmental regulations and corporate sustainability commitments across the healthcare industry.

  • Smart packaging with digital identifiers and connected-device integration is expanding for supply chain security and patient adherence
  • Cell and gene therapy growth is driving demand for ultra-low-volume, temperature-controlled, and aseptically packaged solutions
  • Sustainable packaging mandates are accelerating adoption of recyclable mono-materials and reduced-plastic designs
Talk to a Claight analyst
Do you want to research Healthcare Contract Packaging Services Market Report?

Get in touch and our analysts will be happy to help with custom market sizing, deeper segmentation, supplier detail or a bespoke study built for you.

Connect to an analyst →

Market size and forecast are Claight Analysis, informed by public research and industry data. Historical years before 2025 and all forecast years are Claight estimates at the stated CAGR. Retrieved 2026.